Bain Capital Entities Report Kailera Therapeutics Security Changes
Ticker: KLRA · Form: 4 · Filed: Apr 20, 2026 · CIK: 0002096997
Sentiment: neutral
Topics: insider-filing, ownership-change, sec-form-4
Related Tickers: KLR
TL;DR
Bain Capital entities filed a Form 4 on 4/20/26 for Kailera Therapeutics, reporting ownership changes.
AI Summary
On April 20, 2026, Bain Capital Life Sciences Investors, LLC, along with its related entities Bain Capital Life Sciences IV General Partner, LLC, Bain Capital Life Sciences Fund IV, L.P., and BCLS Fund IV Investments, L.P., filed a Form 4 with the SEC. This filing reports changes in the beneficial ownership of securities for Kailera Therapeutics, Inc. The specific details of the transactions, including the number of shares and dollar amounts, are not provided in this excerpt.
Why It Matters
This filing indicates potential shifts in significant holdings by a major investment firm in Kailera Therapeutics, which could signal changes in the company's ownership structure or strategic direction.
Risk Assessment
Risk Level: medium — Form 4 filings often involve significant investors and can precede market-moving news, but the lack of specific transaction details here limits immediate risk assessment.
Key Players & Entities
- Bain Capital Life Sciences Investors, LLC (company) — Reporting entity
- Bain Capital Life Sciences IV General Partner, LLC (company) — Reporting entity
- Bain Capital Life Sciences Fund IV, L.P. (company) — Reporting entity
- BCLS Fund IV Investments, L.P. (company) — Reporting entity
- Kailera Therapeutics, Inc. (company) — Issuer of securities
- 0001703031 (company) — CIK for Bain Capital Life Sciences Investors, LLC
- 0001996931 (company) — CIK for Bain Capital Life Sciences IV General Partner, LLC
- 0001996979 (company) — CIK for Bain Capital Life Sciences Fund IV, L.P.
- 0002015454 (company) — CIK for BCLS Fund IV Investments, L.P.
FAQ
What specific changes in beneficial ownership were reported by Bain Capital entities for Kailera Therapeutics?
The provided excerpt does not detail the specific transactions, only that a Form 4 was filed on April 20, 2026, reporting changes in beneficial ownership.
When was the Form 4 filing accepted by the SEC?
The Form 4 filing was accepted on April 20, 2026, at 18:01:46.
Which Bain Capital entities are listed as reporting entities in this filing?
Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences IV General Partner, LLC, Bain Capital Life Sciences Fund IV, L.P., and BCLS Fund IV Investments, L.P. are listed as reporting entities.
What is the CIK number for Bain Capital Life Sciences Investors, LLC?
The CIK number for Bain Capital Life Sciences Investors, LLC is 0001703031.
What is the business address for the reporting entities?
The business address for the reporting entities is 200 CLARENDON STREET BOSTON MA 02116.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 20, 2026 regarding Kailera Therapeutics, Inc. (KLRA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.